Fortune India 500 2025 edition
Rank#448- Total income
- ₹5,230 Cr
- Profit
- ₹1,486 Cr
Last year #433
Usv Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹5,637 Cr
▲ 11% YoY
Net profit · FY 2026
₹1,660.1 Cr
Net margin 29.5%
EBITDA · FY 2026
₹2,416.22 Cr
EBITDA margin 42.9%
Authorised capital
₹125 Cr
Registered with MCA
Paid-up capital
₹91.59 Cr
Issued & subscribed
Satisfied charges
₹200.2 Cr
No open charges
Company age
65 yrs
Est. 1961
Employees · EPFO
6,981
Provident fund records
About Usv Private Limited
Data last updated:
Usv Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 August 1961 and has been in existence for over 65 years.
Usv is ranked #448 on the Fortune India 500 (2025). Its director Leena Gandhi Tewari is #75 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1961PTC012098. Its GSTIN is 27AAACU1366N1Z0 (Maharashtra). The company holds 28 GST registrations, of which 20 are active.
The company has an authorised share capital of ₹125 Cr and a paid-up capital of ₹91.59 Cr. It was formerly known as U.S. Vitamin & Pharmaceutical Corporation (India) Limited and Usv Limited. It is led by directors including Prashant Kumar Tewari (Managing Director) and Jayant Dwivedy (Whole-Time Director).
Its last annual general meeting (AGM) was held on 19 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Arvind Vithal Gandhi Chowk B S D Marg Govandi, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2026, the company reported a revenue of ₹5,637 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1,660.1 Cr (net margin 29.5%) and EBITDA of ₹2,416.22 Cr (EBITDA margin 42.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 9% over five years.
The company has about 6,981 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 5 brands: Sebamed India, Mywellnesskart, USV Peptides, Diataal and USV India. As per MCA filings, the company has satisfied charges of ₹200.2 Cr on record. Court records list 323 cases involving the company, including 191 filed by the company and 132 filed against it; 49 cases are pending. The company has 9 deals on record (9 secondary share transfers); the latest was in June 2024. Its 10 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Abbott India Limited with revenue of ₹6,684.73 Cr. The company has 14 MSME Form 1 returns on record between 2018 and 2023, listing 728 overdue payments to 128 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website usvindia.com.
Company details
CIN U24239MH1961PTC012098
Registration Number 012098
Incorporation Date 25 August 1961
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 19 July 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
Name history
Usv has undergone 3 name changes throughout its history. The company was previously known as U.S. Vitamin & Pharmaceutical Corporation (India) Limited, Usv Limited, and U.S. Vitamin & Pharmaceutical Corporation (India) Private Limited. The current legal name is Usv Private Limited.
| Company Name | Status |
|---|---|
| Usv Private Limited | Current |
| U.S. Vitamin & Pharmaceutical Corporation (India) Limited | Previous |
| Usv Limited | Previous |
| U.S. Vitamin & Pharmaceutical Corporation (India) Private Limited | Previous |
CIN history
Usv has one previous CIN (Corporate Identification Number): U24239MH1961PLC012098. The current CIN is U24239MH1961PTC012098, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH1961PTC012098 | Current |
| U24239MH1961PLC012098 | Previous |
Key People
Prashant Kumar Tewari Managing Director Jayant Dwivedy Whole-Time Director Aneesha Gandhi Tewari Director Recognitions & Rankings of Usv
India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#208- Valuation
- ₹28,390 Cr
2023 #192 2022 #176 2021 #202
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #75 Leena Gandhi Tewari ₹38,200 Cr
Contact details
Usv Private Limited's registered office is in Mumbai, Maharashtra. Its website is usvindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressArvind Vithal Gandhi Chowk B S D Marg Govandi, Mumbai, Maharashtra, India – 400088
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Usv Private Limited, buy the company report.
Comprehensive company report
Usv Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Usv operates multiple associated brands including Sebamed India, Mywellnesskart, and USV Peptides. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pH-balanced skin care products for babies and adults globally. | sebamedindia.com | |
| Provides dermatologically tested personal care products with pH 5.5 balance. | mywellnesskart.com | |
| Serves as a CDMO specializing in custom, GMP, and cosmetic peptide synthesis services for clients. | usvpeptides.com | |
| APIs, biosimilars, injectables, peptides, and oral formulations are manufactured. | usvindia.com | |
| Nutritional supplements, vitamins, and minerals for health and wellbeing in India. | diataal.in |
Business activity
The main business activity of Usv is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Usv Private Limited, buy the company report.
Financials of Usv Private Limited
FY 2026 filings availableUsv Private Limited reported revenue of ₹5,637 Cr (up 11% YoY) for FY 2026.
Revenue · FY 2026
₹5,637 Cr ▲ 11%
Net profit · FY 2026
₹1,660.1 Cr margin 29.5%
EBITDA · FY 2026
₹2,416.22 Cr margin 42.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 10%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 15%
5 years · compounded
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 11% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5,637 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,416.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,660.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 42.9% | ||||
| Net Profit Margin | 29.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Usv Private Limited, buy the company report.
Board of directors of Usv Private Limited
Usv has 8 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayant Dwivedy | Whole-Time Director | 16 Apr 2018 | 8 Years 6 Months | Current |
| Aneesha Gandhi Tewari Also directs: Nutritionalab Private Limited | Director | 12 Aug 2022 | 4 Years 2 Months | Current |
| Murugappan Muthiah Venkatachalam Also directs: Avt Natural Products Limited, E.I.D Parry (India) Limited, Parry Agro Industries Limited and 5 more | Director | 31 Jul 2006 | 20 Years 2 Months | Current |
| Vilas Gandhi Tewari | Director | 14 Aug 2012 | 14 Years 2 Months | Current |
| Debabrata Bhadury | Director | 01 May 2001 | 25 Years 5 Months | Current |
| Leena Tewari Gandhi | Director | 20 Jan 1986 | 40 Years 9 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Usv Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abbott India Limited | ₹6,684.73 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Micro Labs Limited | ₹6,499.64 Cr (FY 2025) | -2.0% | Bengaluru, Karnataka, India | |||
| Gland Pharma Ltd | ₹5,830.11 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Usv Private Limitedthis company | ₹5,637 Cr (FY 2026) | ₹1,660.1 Cr | 29.5% | 11.0% | 6,981 | Mumbai, Maharashtra, India |
| Laurus Labs Limited | ₹5,613.89 Cr (FY 2025) | 11.0% | Anakapalle, Andhra Pradesh, India | |||
| Aristo Pharmaceuticals Private Limited | ₹5,363.3 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Eugia Pharma Specialities Limited | ₹4,828.71 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Natco Pharma Limited | ₹4,784 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Ajanta Pharma Limited | ₹4,742.6 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Strides Pharma Science Limited | ₹4,624.06 Cr (FY 2025) | 18.0% | Thane, Maharashtra, India | |||
| Granules India Limited | ₹4,494.53 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Usv Private Limited, buy the company report.
Auditor
Usv Private Limited is audited by Walker Chandiok & Co LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Co LLP | FY 2024 | 001076N/N500013 |
Shareholding
The shareholding of Usv Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Usv Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹200.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jul 2011 | 10302134 | Axis Bank Limited | ₹80 Cr | Satisfied | |
| 21 Jul 2011 | 10301593 | Axis Bank Limited | ₹80 Cr | Satisfied | |
| 15 Oct 2009 | 10181441 | Department of Biotechnology | ₹1.2 Cr | Satisfied | |
| 14 Dec 1999 | 80053216 | State Bank of India | ₹39 Cr | Satisfied |
To see the full charge records of Usv Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Usv Private Limited has 9 deals on record (9 secondary share transfers); the latest was in June 2024.
Total deals
9
Secondary share transfers
9
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2024 | Secondary share transfer | Undisclosed | Buyer: Atlas Family Trust, Shakti Family Trust, Ananda Family Trust Seller: Vilas Family Trust, Aneesha Family Trust, 2 individuals |
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2023 | Secondary share transfer | Undisclosed | Seller: an individual |
| Sep 2022 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| Dec 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Reliable Developments Private Limited , Treva Health Care Private Limited , Vipal Health Care Private Limited |
To see the full deal history of Usv Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Usv Private Limited has 323 court cases on record: 191 filed by Usv, 132 filed against it. 49 cases are pending and 274 are disposed.
Total cases
323
Filed by the company
191
Filed against the company
132
Pending
49
Disposed
274
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 229 | 85 | 32 |
| District courts | 71 | 30 | 13 |
| Supreme Court | 16 | 10 | 0 |
| NCLAT | 7 | 7 | 4 |
Cases on record (5 of 323)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Intas Pharmaceuticals Limited Through Its Authorised Sign. Mehul Pathak | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Intas Pharmaceuticals Limited & Anr. | Pending |
| High Court | Court case (CMP(TM)) | Filed against the company by M/S Aurobindo Pharma Limited | Pending |
| NCLAT, Court III | Tribunal matter | Filed against the company by Darshan Gandhi, Ex-Director, Lok Housing & Constructions Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Wipro Enterprises Pvt Ltd | Pending |
To see the full case history of Usv Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Usv Private Limited was last rated by Crisil on 30 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 30 Dec 2020 |
To see the full credit ratings and regulatory alerts of Usv Private Limited, buy the company report.
MSME payment delays
Usv Private Limited has 14 MSME Form 1 returns on record between 2018 and 2023, listing 728 overdue payments to 128 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 128)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Omkar Traders | |||
| Shree Chemicals | |||
| Mitsu Chem Plast Limited | |||
| Sheth Impression LLP | |||
| Medicin Consultancy Services |
To see the full MSME payment records of Usv Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Usv has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Arvind Vithal Gandhi Foundation | U85300MH2022NPL378248 |
To see the full group structure of Usv Private Limited, buy the company report.
Employees & EPFO
Usv Private Limited has a workforce of 6,981 employees on its EPFO records as of Aug 10, 2025, across 1 active EPFO establishment.
Employee count
6,981
Active EPFO establishments
1
Employee growth
9.18%
GST
Usv has 28 GST registrations: 20 active and 8 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
28
Active
20
Cancelled / inactive
8
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACU1366N1Z0 | Maharashtra | Active | 01 Jul 2017 |
| 27AAACU1366N2ZZ | Maharashtra | Active | 16 Oct 2017 |
| 02AAACU1366N1ZC | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAACU1366N1ZA | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Usv Private Limited, buy the company report.
Recent activity
Usv Private Limited has 17 board changes on record since 1986: 8 appointments and 9 cessations. The latest: Debabrata Sujit Gupta was appointed as Director on 07 Jun 2024.
Filing
Usv Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai.
AGM
Usv Private Limited last Annual general meeting of members was held on 19 Jul 2025 as per latest MCA records.
Appointed
Debabrata Sujit Gupta was appointed as Director.
Ceased
Aneesha Gandhi Tewari ceased to be Additional Director.
Appointed
Aneesha Gandhi Tewari was appointed as Director.
Ceased
Akhilesh Jain ceased to be Company Secretary.
Ceased
Deepak Keshav Ghaisas ceased to be Director.
Appointed
Jayant Dwivedy was appointed as Whole-Time Director.
Ceased
Anil Bhalchandra Kale ceased to be Company Secretary.
Ceased
Prakash Chandrasekharan Menon ceased to be Cfo(Kmp).
Ceased
Jayant Dwivedy ceased to be Additional Director.
Ceased
Debabrata Sujit Gupta ceased to be Whole-Time Director.
18 earlier events are in the company report.
News
From our blog
Frequently asked questions
Usv is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 August 1961 (65+ years old) and is registered under CIN U24239MH1961PTC012098.
Usv has 8 current directors:
- Prashant Kumar Tewari - Managing Director
- Jayant Dwivedy - Whole-Time Director
- Aneesha Gandhi Tewari - Director
- Murugappan Muthiah Venkatachalam - Director
- Vilas Gandhi Tewari - Director
- Debabrata Bhadury - Director
- Leena Tewari Gandhi - Director
- Debabrata Sujit Gupta - Director
The latest financial statements of Usv on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 19 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Usv is 27AAACU1366N1Z0, registered in Maharashtra. The company has 28 GST registrations in all, of which 20 are active and 8 are cancelled or inactive. Other active GSTINs include 27AAACU1366N2ZZ (Maharashtra), 02AAACU1366N1ZC (Himachal Pradesh), 03AAACU1366N1ZA (Punjab).
The CIN (Corporate Identification Number) of Usv is U24239MH1961PTC012098. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Usv has 323 court cases on record: 191 filed by the company and 132 filed against it. 49 are pending. Most are in the high courts.
Usv was incorporated on 25 August 1961, making it 65+ years old. It is registered with the Registrar of Companies, Mumbai.
Usv has 9 deals on record (9 secondary share transfers); the latest was in June 2024.
The peers of Usv by revenue are Abbott India Limited, Micro Labs Limited, Gland Pharma Ltd, Laurus Labs Limited, Aristo Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Debabrata Sujit Gupta was appointed as Director on 07 Jun 2024. Aneesha Gandhi Tewari ceased to be Additional Director on 17 Jul 2023. Aneesha Gandhi Tewari was appointed as Director on 12 Aug 2022. Usv has 17 board changes on record in total.
Usv has 14 MSME Form 1 returns on record between 2018 and 2023, listing 728 overdue payments to 128 micro and small suppliers. The latest return was filed on 30 Aug 2023.
Usv can be reached through the website usvindia.com. Its registered office is in Mumbai, Maharashtra, India.